To The Moon

👍👍👍👍👍👍👍👍👍👍👍👍

Fingers to be fast to tap on it

Thank for this game 

GSK announced on Thursday that its subsidiary ViiV Healthcare has received approval from China’s National Medical Products Administration for ‘Vocabria’, or cabotegravir, injection in combination with Janssen’s ‘Rekambys’ for treating HIV-1 in adults. The approval followed the prior authorisation of cabotegravir injection and tablets in China in July. It said the combination therapy was an alternative to daily oral medication for people with HIV-1 and addressed potential adherence challenges, given that more than one million people were living with HIV in China as of October 2020.

GSK announced on Thursday that its subsidiary ViiV Healthcare has received approval from China’s National Medical Products Administration for ‘Vocabria’, or cabotegravir, injection in combination with Janssen’s ‘Rekambys’ for treating HIV-1 in adults. The approval followed the prior authorisation of cabotegravir injection and tablets in China in July. It said the combination therapy was an alternative to daily oral medication for people with HIV-1 and addressed potential adherence challenges, given that more than one million people were living with HIV in China as of October 2020.

Hello everyone let's join lightings game 

Haha let's catch something here

Let's play lighting game to win some prizes 

Thanks you the lighting games nice nice

Thank u for lighting games